相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal Autapses
Peng Xia et al.
JOURNAL OF NEUROSCIENCE (2010)
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
Junko Sasaki et al.
NATURE (2010)
High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain
Qing Wang et al.
EXPERIMENTAL NEUROLOGY (2009)
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors
David Wheeler et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
Anamitra Ghosh et al.
JOURNAL OF NEUROSCIENCE (2009)
Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling
Piotr Michaluk et al.
JOURNAL OF NEUROSCIENCE (2009)
Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats
M. A. Galic et al.
NEUROBIOLOGY OF DISEASE (2009)
GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo
Neng-Wei Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Use of statins and the risk of Parkinson's disease - A retrospective case-control study in the UK
Claudia Becker et al.
DRUG SAFETY (2008)
Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain
E. -M. Harre et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine
Jezabel Rodriguez-Blanco et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide
Maria del Carmen Hemandez-Romero et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Hypoxia-Inducible Factor-1α Protects Cultured Cortical Neurons from Lipopolysaccharide-Induced Cell Death via Regulation of NR1 Expression
Shiu-Hwa Yeh et al.
JOURNAL OF NEUROSCIENCE (2008)
Non-dopaminergic treatments in development for Parkinson's disease
Susan H. Fox et al.
LANCET NEUROLOGY (2008)
Anxiety Rating Scales in Parkinson's Disease: Critique and Recommendations
Albert F. G. Leentjens et al.
MOVEMENT DISORDERS (2008)
Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease
Shirley W. Y. Tsang et al.
NEUROBIOLOGY OF AGING (2008)
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
C. Cramer et al.
NEUROLOGY (2008)
EMOTIONAL, COGNITIVE AND NEUROCHEMICAL ALTERATIONS IN A PREMOTOR STAGE MODEL OF PARKINSON'S DISEASE
M. T. Tadaiesky et al.
NEUROSCIENCE (2008)
Analysis of NR3A receptor subunits in human native NMDA receptors
Anna Nilsson et al.
BRAIN RESEARCH (2007)
Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypes
Stephan Niemann et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage
Li Tian et al.
JOURNAL OF CELL BIOLOGY (2007)
Synaptic scaffolding molecule α is a scaffold to mediate N-methyl-D-aspartate receptor-dependent RhoA activation in dendrites
Junko Iida et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The NMDA receptor antagonist CPP blocks the effects of predator stress on pCREB in brain regions involved in fearful and anxious behavior
Jacqueline Blundell et al.
BRAIN RESEARCH (2007)
P53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
Makio Mogi et al.
NEUROSCIENCE LETTERS (2007)
Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala
V. M. Pickel et al.
NEUROSCIENCE (2006)
Reproductive experience reduces the sedative, but not anxiolytic effects of diazepam
Elizabeth M. Byrnes et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors
Philip L. Johnson et al.
JOURNAL OF NEUROSCIENCE (2006)
Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture
C Wang et al.
TOXICOLOGICAL SCIENCES (2006)
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking
PJ Hallett et al.
JOURNAL OF NEUROSCIENCE (2006)
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease
MT Armentero et al.
NEUROBIOLOGY OF DISEASE (2006)
Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD
F Bibbiani et al.
EXPERIMENTAL NEUROLOGY (2005)
Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment
CR Yang et al.
NEUROSCIENTIST (2005)
Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats
Q Wang et al.
BRAIN RESEARCH (2005)
Histological, belhavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease
H Yuan et al.
JOURNAL OF NEUROSCIENCE METHODS (2005)
High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex:: possible involvement of endothelial nitric oxide synthase
Q Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice
ML Selley
BRAIN RESEARCH (2005)
Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies
WGM Janssen et al.
EXPERIMENTAL NEUROLOGY (2005)
Dopamine-glutamate interaction and antipsychotics mechanism of action: Implication for new pharmacological strategies in psychosis
A de Bartolomeis et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Rationale for and use of NMDA receptor antagonists in Parkinson's disease
PJ Hallett et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Life long changes in cognitive ability are associated with prescribed medications in old age
JM Starr et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology
AJ Mishizen-Eberz et al.
NEUROBIOLOGY OF DISEASE (2004)
blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons
C Wang et al.
NEUROSCIENCE (2004)
Differential expression and ser897 phosphorylation of striatal N-methyl-D-aspartate receptor subunit NR1 in animal models of Parkinson's disease
R Betarbet et al.
EXPERIMENTAL NEUROLOGY (2004)
Long-term statin use and psychological well-being
Y Young-Xu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease
H Bi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain
T Araki et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
